Related Experiment Video
Updated: Apr 2, 2026

Multimodality Diagnosis of Mesenteric Ischemia
Published on: July 21, 2023
Olmesartan-Associated Enteropathy: A Review of Clinical and Histologic Findings
Eun-Young Karen Choi1, Barbara J McKenna
1From the Department of Pathology, University of Michigan, Ann Arbor.
Abstract:
Olmesartan is an antihypertensive medication belonging to the angiotensin II receptor blocker class of drugs that has recently been associated with severe enteropathy. Olmesartan-associated enteropathy is uncommon and may be difficult to recognize because of its clinical and histologic similarities to other clinical entities, including celiac sprue and autoimmune enteropathy. The purpose of this article is to review the clinical and histologic findings of olmesartan-associated enteropathy that have been reported in the literature and to discuss clinical entities to consider in the differential diagnosis of olmesartan-associated enteropathy.
More Related Videos
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
12:29Rat Mesentery Exteriorization: A Model for Investigating the Cellular Dynamics Involved in Angiogenesis
Published on: May 20, 2012